Joyner J, Neves L A A, Stovall K, Ferrario C M, Brosnihan K B
Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157-1032, USA.
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R1073-80. doi: 10.1152/ajpregu.00572.2007. Epub 2008 Jan 9.
We previously demonstrated that kidney and urine levels of angiotensin-(1-7) [ANG-(1-7)] were increased in pregnancy. To explore the role of ANG-(1-7) on fluid and electrolyte homeostasis during pregnancy, we evaluated the effect of the ANG-(1-7) antagonist D-alanine-[ANG-(1-7)] (A-779) on kidney function. Virgin and pregnant rats received infusion of vehicle or A-779 (48 microg.kg(-1).h(-1)) for 8 days by osmotic minipumps. Metabolic studies were done on treatment day 7-8. Virgin and pregnant rats at day 15 and 19 were killed, and blood and kidneys were collected. Kidneys were prepared for Western blot analysis for aquaporin-1 (AQP1) and aquaporin-2. In virgin female rats, A-779 increased urine volume and decreased urinary osmolality and AQP1 with no change in water intake. In 19-day pregnant rats, A-779 significantly decreased water intake and urine volume and increased urinary osmolality and kidney AQP1 expression. Only in late gestation did A-779 treatment decrease the difference between intake and output (balance). A-779 treatment increased plasma vasopressin in late gestation but did not change vasopressin in virgins. In virgin and pregnant animals, A-779 administration had no effect on blood pressure, plasma volume, blood volume, or urinary electrolytes. These results suggest that ANG-(1-7) produces antidiuresis associated with upregulation of AQP1 in virgin rats, whereas ANG-(1-7) produces diuresis in late gestation with downregulation of AQP1. ANG-(1-7) contributes to the enhanced water intake during pregnancy, allowing maintenance of the normal volume-expanded state despite diuresis produced in part by decreased AVP and AQP1.
我们之前证明,孕期肾脏和尿液中血管紧张素-(1-7)[ANG-(1-7)]水平升高。为探究ANG-(1-7)在孕期体液和电解质稳态中的作用,我们评估了ANG-(1-7)拮抗剂D-丙氨酸-[ANG-(1-7)](A-779)对肾功能的影响。未孕和孕鼠通过渗透微型泵输注溶媒或A-779(48μg·kg⁻¹·h⁻¹),持续8天。在治疗的第7至8天进行代谢研究。处死妊娠第15天和19天的未孕和孕鼠,采集血液和肾脏。制备肾脏用于水通道蛋白-1(AQP1)和水通道蛋白-2的蛋白质印迹分析。在未孕雌性大鼠中,A-779增加尿量,降低尿渗透压和AQP1,而水摄入量无变化。在妊娠19天的大鼠中,A-779显著降低水摄入量和尿量,增加尿渗透压和肾脏AQP1表达。仅在妊娠晚期,A-779治疗才降低摄入量与排出量之间的差异(平衡)。A-779治疗在妊娠晚期增加血浆血管加压素,但对未孕鼠的血管加压素无影响。在未孕和孕鼠中,给予A-779对血压、血浆容量、血容量或尿电解质无影响。这些结果表明,ANG-(1-7)在未孕大鼠中产生抗利尿作用,与AQP1上调相关,而在妊娠晚期ANG-(1-7)产生利尿作用,同时AQP1下调。ANG-(1-7)有助于孕期水摄入量增加,尽管部分利尿是由抗利尿激素(AVP)和AQP1减少所致,但仍能维持正常的容量扩张状态。